Skip to main content

Hormone Replacement Therapy: Shortages

Question for Department of Health and Social Care

UIN 2047, tabled on 13 February 2020

To ask the Secretary of State for Health and Social Care, if he will commission an independent inquiry into the causes of shortages of Hormone Replacement Therapy (HRT) medications and products.

Answered on

24 February 2020

The Department is aware that the ongoing supply issues with some hormone replacement therapy (HRT) preparations are due to a range of issues including manufacturing issues, regulatory issues and problems accessing the raw pharmaceutical ingredient as well as commercial decisions made by some companies to divest these products. Although some HRT products are affected by supply issues, supplies of other alternative HRT products remain available.

We are in regular discussion with all HRT suppliers about the underlying causes behind these issues and are working with them closely to resolve the situation as quickly as possible. We therefore have no plans to commission an independent inquiry.

We anticipate the overall supply situation for HRT products will improve from the end of this month.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.